PhaseBio Pharmaceuticals Operating Expenses 2011-2026 | PHAS

Annual Operating Expenses PhaseBio Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
118 M	85.2 M	42.1 M	20.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
118 M	20.3 M	66.4 M

Quarterly Operating Expenses PhaseBio Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	25.5 M	18.3 M	-	28.9 M	31.4 M	25.6 M	-	20.5 M	24.1 M	14.6 M	-	11.8 M	10.2 M	8.04 M	-	5.41 M	4.11 M	2.88 M	-	1.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
31.4 M	1.9 M	15.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	20.7 M	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	127 M	$ 33.23	-4.03 %	$ 584 M	USA
Graybug Vision GRAY	23.1 M	-	-11.23 %	$ 9.65 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	948 M	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	292 M	$ 3.72	-2.75 %	$ 1.11 B	Canada
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	99.1 M	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	304 M	$ 64.66	-1.37 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	106 M	$ 8.52	-2.46 %	$ 1.39 B	Britain
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
Certara CERT	237 M	$ 7.16	1.49 %	$ 1.15 B	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Capricor Therapeutics CAPR	49.3 M	$ 25.91	-3.56 %	$ 694 M	USA
Catalyst Pharmaceuticals CPRX	206 M	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Codexis CDXS	31.5 M	$ 0.99	-3.28 %	$ 72.7 M	USA
Corvus Pharmaceuticals CRVS	23.4 M	$ 17.75	-0.79 %	$ 852 M	USA
CTI BioPharma Corp. CTIC	47.8 M	-	-	$ 1.2 B	USA
CohBar CWBR	12.4 M	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	12 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	12 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Denali Therapeutics DNLI	502 M	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Eton Pharmaceuticals ETON	22.3 M	$ 17.54	-3.36 %	$ 450 M	USA
Entasis Therapeutics Holdings ETTX	52.3 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	104 M	-	7.55 %	$ 38.1 M	USA